Clinical Trial Update: A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 study of YL-13027 in combination with sintilimab in patients with advanced solid tumors is ongoing (Phase 1 and Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Sintilimab (sintilimab)
• YL-13027

Snippet

Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd. | Conditions: Advanced Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN